期刊文献+

改良局部枸橼酸抗凝在儿童血液滤过的应用 被引量:1

Application of improved regional citrate anticoagulation in child hemofiltration
下载PDF
导出
摘要 目的探讨透析泵泵注枸橼酸在儿童局部枸橼酸抗凝(RCA)连续性血液滤过(CHF)中的应用。方法回顾性分析2015年9月至2017年1月重庆医科大学附属儿童医院重症监护室49例行RCA-CHF治疗患儿的临床资料,分为传统组20例行RCA-CHF治疗;改良组29例(以透析泵泵注枸橼酸)在连续性血液透析滤过模式下行RCA-CHF治疗。观察输液泵气泡报警、采血不良、出凝血等不良事件,滤器寿命及枸橼酸抗凝常见并发症等发生情况。结果两组气泡报警、滤器寿命比较,差异有统计学意义(P<0.05);两组治疗前后生化指标比较中,Na^+、iCa^(2+)、TCa^(2+)/iCa^(2+)及HCO_3^-比较,差异均有统计学意义(P<0.05),但治疗前、后改良组与传统组Na^+、iCa^(2+)、TCa^(2+)/iCa^(2+)及HCO_3^-比较,差异均无统计学意义(P>0.05)。结论透析泵代替枸橼酸泵的改良技术可以更安全有效地用于儿童RCA-CHF治疗。 Objective To investigate the application of citrate injected by dialysis pump in regional citrate anticoagulation(RCA)for child continuous hemofiltration(CHF).Methods The clinical data of 49 children patients with RCA-CHF with citrate anticoagulation in ICU of the Affiliated Children′s Hospital of Chongqing Medical University from September 2015 to January 2017 were retrospectively analyzed.All cases were divided into the traditional group(20 cases)for conducting RCA-CHF treatment and improved group(29 cases,dialysis pump injection of citric acid)for conducting RCA-CHF under CHF mode.The occurence situation of common complications such as infusion pump bubble alarming,blood undesirable collection,bleeding and coagulation,and complications such as filter lifetime and citrate anticoagulation were observed.Results The bubble alarming and filter lifetime had statistical difference between the two groups(P0.05).The biochemical indicators before and after treatment,and Na^+,iCa^2+,TCa^2+/iCa^2+ and HCO3^- before and after treatment had statistical difference between the two groups.But Na^+,iCa^2+,TCa^2+/iCa^2+ and HCO3^- before and after treatment had no statistical difference between the improved group and traditional group(P0.05).Conclusion The improved technology of dialysis pumps instead of citrate pumps can more safely and more effectively use in child RCA-CHF treatment.
出处 《重庆医学》 CAS 北大核心 2017年第30期4200-4203,共4页 Chongqing medicine
基金 百利儿科科研基金资助项目(B2016-A-3)
关键词 血液滤过 儿童 抗凝药 肾替代疗法 局部枸橼酸抗凝 regional citrate anticoagulation(RCA) continuous hemofiltration(CHF) clinical data RCA-CHF ICU Affiliated Children′s Hospital Chongqing Medical University
  • 相关文献

参考文献5

二级参考文献62

  • 1桂保松,赵光本,昝瑛,马小琴,赵莉,卫小红.新型枸橼酸盐抗凝血液透析液溶质清除效果研究[J].中国实用内科杂志,2005,25(4):328-330. 被引量:4
  • 2鄢建军,杨瑞,杜翔,张仲华.改良连续静-静脉血液滤过中局部枸橼酸抗凝的应用[J].护理学杂志(综合版),2006,21(4):4-6. 被引量:19
  • 3樊寻梅.儿科感染性休克(脓毒性休克)诊疗推荐方案[J].中华儿科杂志,2006,44(8):596-598. 被引量:205
  • 4Monehi M, Berghmans D, Ledoux D, et al. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration : a prospective randomized study [J]. Intensive Care Med, 2004,30 : 260 - 265.
  • 5Kutsogiannis DJ, Gibney NRT, Stollery D, et al. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients [ J ]. Kidney International,2005, 67:2361 - 2367.
  • 6Bagshaw SM, Laupland KB, Boiteau PJ,et al. Is regional citrate superior to systemic heparin antieoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system [ J ]. J Crit Care,2005,20 ( 2 ) : 155 - 161.
  • 7Oudemans SHW, Bouman RJ, Koopmans M, et al. Citrate anticoagulation for eontinous venovenous hemofiltration [ J ]. Crit Care Meal,2009,37 (2) :545 - 552.
  • 8Cassina T, Mauri R, Engeler Aet al. Continuous veno-venous hemofiltration with regional citrate antieoagulation : a four-year singlecenter experience. Int J Artif Organs. 2008,31 ( 11 ) :937 -943.
  • 9Tolwani AJ,Wine KM. Anticoagulation for continuous renal replacement therapy[J]. Semin Dial,2009,22(2) : 14-15.
  • 10Binici DN,Gunes N. Risk factors leading to reduced bone mineral den- sity in hemodialysis patients with metabolic syndrome[J]. Ren Fail, 2010,32(4) :469-474.

共引文献310

同被引文献24

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部